Llwytho...
Assessing cost-utility of predictive biomarkers in oncology: a streamlined approach
Evaluation of cost-utility is critical in assessing the medical utility of predictive or prognostic biomarkers. Current methods involve complex state-transition models, requiring comprehensive data inputs. We propose a simplified decision-analytic tool to explore the relative effect of factors contr...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Breast Cancer Res Treat |
|---|---|
| Prif Awduron: | , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5990969/ https://ncbi.nlm.nih.gov/pubmed/26749360 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-016-3677-3 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|